&w=3840&q=100)
OneSource eyes weight-loss drug boost to order book
Global drugmakers, including generic drug manufacturers in India, are racing to develop their versions of blockbuster injectable obesity drugs from Denmark's Novo Nordisk and U.S.-based Eli Lilly. The active chemical compound in Novo's injectable Wegovy drug, semaglutide, will go off patent in 2026 in a few markets, including India.
OneSource, which added 15 orders related to obesity and diabetes drugs in fiscal year 2025, said there are more in the pipeline. The global obesity market is estimated to be valued at $150 billion by the early 2030s.
The company develops and manufactures complex biological drugs, vials, injectables, and soft gelatin capsules for larger pharmaceutical firms.
"Our growth over the next few years will be driven by commercial launches of GLP-1s (weight-loss and diabetes drugs) by our global customers in all the key markets opening post patent expiry in 2026," CEO Neeraj Sharma told Reuters in an interview.
Backed by increasing demand from weight-loss drug manufacturers, OneSource's order book across all service verticals should expand in line with 30% compound annual growth rate through fiscal year 2028, according to the CEO.
OneSource, which competes with larger players such as Piramal Pharma and Divi's in contract research, development and manufacturing, is investing about $100 million to expand its drug device facilities, the CEO said.
The company, which was demerged from Strides Pharma Science and listed in January, is also looking at setting up a global footprint in manufacturing, both in Europe and the U.S.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
7 minutes ago
- India.com
Indian Rupee Strengthens Against Us Dollar Despite Tariff Concerns
New Delhi: The Indian rupee opened stronger on Monday, amid additional 25 per cent tariff proposed by US President Donald Trump on India, which is set to take effect from August 27. The rupee likely inched up higher on optimism that the Russia-Ukraine war will end following the upcoming US-Russia negotiations on August 15, leading to removal of additional tariffs on India. The local currency opened 13 paise stronger at 87.53 against the US dollar up from 87.66 on Friday. The immediate trading range is expected to be between 87.25 and 87.80, according to analysts. The Indian rupee was expected to open with small gains today at 87.51, while markets are awaiting US and domestic inflation data. Indian markets are focused on domestic CPI and WPI inflation data, set to be released on August 12 and August 14. Additional tariffs, if implemented, are expected to put pressure on the Indian rupee against the US dollar in the short term due to reduced export revenues, capital outflows, and inflationary pressures. US' new tariffs on India are expected to affect sectors such as textiles, leather, and seafood. India sharply criticised the tariffs, calling it "unfair and unreasonable". US has singled out India for the harshest tariff rate of 50 per cent, compared to 30 per cent for China and 15 per cent for Turkey, despite all three countries importing Russian oil. Brent oil prices dropped to $66.25 per barrel in Asian trade on Monday morning, continuing last week's significant declines as traders anticipated upcoming talks between Russia and the US will ease the Ukraine conflict. China released soft inflation data and economic indicators in July, indicating that the economy was recovering slowly, leaving oil markets largely pessimistic about future demand. FII selling persisted during the week in Indian equity markets, indicating broader risk aversion in emerging markets. However, ongoing purchases by DIIs helped mitigate losses.
Indian Express
7 minutes ago
- Indian Express
Why pineapple is the anti-inflammatory superfood we all need
Written by Simrat Kathuria Pineapple is much more than a tasty treat with its golden flesh and tropical scent. This fruit has significant nutrition value, primarily due to the vitamins, minerals and bioactive substances it contains. But it is that superfruit which can effectively address heart disease, diabetes, liver health and obesity, all of which Indians are more vulnerable to. However, we have to eat it mindfully. Good for heart health Pineapple is higher in bromelain, an enzyme that offers both anticoagulant and anti-inflammatory benefits. Research indicates that the bromelain in pineapple may assist with the reduction of clotting leading to improved blood flow and lower risk of a cardiovascular event like a heart attack or stroke. In addition to bromelain, pineapple has high levels of vitamin C, which supports the health of arterial walls, and potassium to regulate blood pressure, which is particularly important in India, where one in three adults may have hypertension. Can diabetics have it? While pineapple does contain sugar, it can still fit inside a diabetic approach to eating — if you have some moderation. Although it has a moderate glycemic index (GI around 59), fresh pineapple (keep in mind, eating it fresh) will not drastically raise blood sugars when eaten in small amounts. Pineapple also has the added benefit of high fibre (and water) content, which abates the absorption of the sugar component of the fruit. Canned pineapple or juice, which has added ingredients and high sugar levels should be avoided. Diabetics might consider approximately ½ cup (50–75 grams) of fresh pineapple (likely with a protein or healthy fat) for sweet treats, maintaining blood sugar and glucose levels. With Indian diets often containing processed oils and heavier spices, liver overload is becoming a significant public health issue. Since pineapple is high in antioxidants like vitamin C, manganese and flavonoids, it can act against oxidative stress, the main contributor to liver damage. Bromelain supports digestion, helping decrease inflammation, possibly lessening the burden on the liver for detoxification. In a controlled but frequent consumer, it can be supportive in normalizing liver function and protection against fatty liver disease. Pineapple is relatively low in calories (42 kcal per 100g) and fat-free, which can be draining for those wanting a tasty snack when managing weight loss targets. Its natural sweetness is great for taming sugar cravings and natural hydration while its fibre load contributes to the feeling of satiety. Bromelain can help break down proteins so that they can be easily absorbed by the body. Pineapple can be a good strategy to include in your mid-morning or afternoon snack breaks. Aim for around one cup (150 grams) per day, provided you are enjoying it as part of a balanced diet and keeping to your daily calorie allowance. (Kathuria is a clinical dietician and celebrity coach)
&w=3840&q=100)
Business Standard
7 minutes ago
- Business Standard
US green card age rule change: How it may hit children, H-1B visa holders
A recent change by the US Citizenship and Immigration Services (USCIS) will narrow the eligibility for children to remain on their parent's green card application, affecting thousands of immigrant families — including many on H-1B visas. From August 15, 2025, adjustment of status applications will be assessed under a stricter standard. Children turning 21 before approval will lose eligibility unless they qualify under the revised Child Status Protection Act (CSPA) calculation. How the rule has changed Under the Biden administration's February 2023 policy, USCIS used the more generous 'dates for filing' chart to decide if a child's age could be frozen under the CSPA, giving families extra time. From August 15, the agency will revert to the 'final action dates' chart — a less favourable benchmark that often shortens the protection window. 'The Immigration and Nationality Act defines a child as a person who is both unmarried and under 21 years old,' USCIS explained in its announcement. 'If someone applies for lawful permanent resident status as a child but turns 21 before being approved, that person can no longer be considered a child for immigration purposes. This is commonly referred to as 'ageing out'.' USCIS said Congress had created the CSPA in 2002 to address backlogs causing children to lose eligibility before their case was decided. The law allows an age calculation — the 'CSPA age' — that can keep a child under 21 for immigration purposes even after their actual birthday, but only if they remain unmarried. Why this matters for Indian families The change will hit the Indian diaspora particularly hard. India has one of the world's longest waits for an employment-based green card, with backlogs stretching into decades. A March 2023 analysis by David J. Bier, director of immigration studies at the Cato Institute, found a queue of 1.07 million Indians in the EB-2 and EB-3 categories. Bier projected that nearly 134,000 children in these families could age out before a green card becomes available — a figure that could now rise under the revised calculation. How the CSPA works For employment-based green card cases, several conditions must be met for a child to remain eligible: • The I-140 petition must be approved • The I-485 adjustment of status application must be filed • The priority date must be current • The child must be under 21 after subtracting the time the I-140 was pending For example, if an I-140 was pending for one year, that year is deducted from the child's age. The same principle applies in family-based cases using the I-130 petition. Impact of the new calculation 'This means that some children, even with a filed I-485, could lose eligibility if they turn 21 before the final action date is current,' said Reddy Neumann, a US-based immigration attorney. 'This change essentially reverts the policy to how it was before the more flexible approach in recent years.' Neumann added, 'Once a child's age is locked in under CSPA, no further worry is needed. But for those not yet protected, timing is crucial. While it's possible to file the I-485 with a pending I-140, the age lock-in only occurs when the I-140 is approved and the final action date is current.' Doug Rand, a former Department of Homeland Security official who worked on the 2023 policy, called the change unnecessary. 'It's such a petty and obnoxious thing to do. Of course, the Trump administration is causing fear and heartbreak at a massive scale, across the immigration system, and this may seem like a small thing in the grand scheme,' he said. What should applicants do? Attorneys may consider strategies such as adjusting premium processing timelines to maximise the pending period of an I-140, which can benefit age calculations. 'This is a case-by-case decision that should be carefully planned with legal advice,' said Neuman
